ASCEND BY NTHRYS
Research Abroad Products

Exomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 97–108 of 200 project topics
Clonal Evolution Tracking Software for Treatment Resistance
A computational platform that analyzes serial exome samples to map tumor clonal heterogeneity and predict therapeutic resistance mechanisms in real-time. Creates recurring revenue through enterprise licensing to comprehensive cancer centers and pharmaceutical research organizations.
Cancer Exomics Diagnostics Platform Dev Click to view more details →
Regulatory-Compliant Cancer Exome Reporting Infrastructure
A white-label SaaS infrastructure delivering CLIA/CAP-validated exome analysis reports with automated clinical variant interpretation and physician-ready summaries. Monetizes through platform licensing fees to diagnostic labs seeking to launch cancer exome services without infrastructure investment.
Cancer Exomics Diagnostics Platform Dev Click to view more details →
Tumor Mutational Burden Quantification and Immunotherapy Matching
A diagnostic platform calculating tumor mutational burden from exome data to predict immunotherapy response and guide checkpoint inhibitor selection. Captures revenue through clinical testing services, pharma partnerships for biomarker-driven trials, and oncology center subscriptions.
Cancer Exomics Diagnostics Platform Dev Click to view more details →
De Novo Cancer Variant Database and Annotation Licensing Service
A proprietary, continuously updated cancer variant knowledge base providing labs with curated annotations, clinical interpretations, and evidence summaries for somatic mutations. Generates subscription revenue through tiered licensing models serving diagnostic labs, research institutions, and pharmaceutical companies.
Cancer Exomics Diagnostics Platform Dev Click to view more details →
Exosome Isolation and Purification Service Platform
A commercial bioprocessing service that isolates and purifies patient-derived exosomes using proprietary chromatography and ultracentrifugation technologies for therapeutic manufacturers. This platform generates recurring revenue through fee-for-service contracts with pharma companies developing exosome-based therapeutics.
Exosome Drug Delivery Technology Platform Click to view more details →
AI-Powered Exosome Cargo Loading Optimization Software
An SaaS platform using machine learning to predict and optimize therapeutic payload loading into exosomes, reducing development time and material waste. The software licenses generate predictable subscription revenue while accelerating customer drug development timelines.
Exosome Drug Delivery Technology Platform Click to view more details →
Exosome Manufacturing Scale-Up and cGMP Production Service
A contract manufacturing organization (CMO) specializing in scaling exosome production to clinical and commercial volumes under cGMP standards. This service model captures significant margin on volume-based pricing while establishing long-term partnerships with biotech and pharmaceutical clients.
Exosome Drug Delivery Technology Platform Click to view more details →
Clinical-Grade Exosome Quality Control Testing Platform
A diagnostic testing service offering particle size analysis, protein quantification, RNA integrity, and potency assays for exosome drug candidates entering clinical trials. Revenue derives from per-sample testing fees and premium tiered packages for comprehensive release testing.
Exosome Drug Delivery Technology Platform Click to view more details →
Exosome Surface Engineering and Targeting Technology Toolkit
A modular software and reagent platform enabling rapid surface modification of exosomes with targeting ligands and imaging markers for tissue-specific delivery applications. The platform generates revenue through tool licensing, reagent sales, and technical consultation services.
Exosome Drug Delivery Technology Platform Click to view more details →
Exosome Immunogenicity and Safety Profiling Service Bureau
A specialized testing service conducting immunogenicity screening, off-target toxicity assessment, and biocompatibility validation for exosome therapeutics destined for clinical use. This service addresses regulatory requirements and generates revenue through tiered assay packages and consultation fees.
Exosome Drug Delivery Technology Platform Click to view more details →
Exosome Bank and Biorepository Management Information System
A cloud-based platform managing sample tracking, metadata organization, and inventory control for research institutions and companies storing clinical-grade exosomes. Revenue streams include platform licensing fees, sample storage subscription charges, and data analytics premium tiers.
Exosome Drug Delivery Technology Platform Click to view more details →
Real-Time Exosome Biodistribution Monitoring Technology Platform
A proprietary imaging and tracking platform using labeled exosomes and clinical-grade sensors to monitor in vivo delivery and biodistribution in preclinical and clinical studies. The platform generates revenue through licensing agreements, imaging service fees, and instrument rentals.
Exosome Drug Delivery Technology Platform Click to view more details →